Presentation AHA 2018 DECLARE - TIMI 58 Presenter: Stephen Wiviott November 11, 2018 REGISTER for free or LOG IN to view this content Heart Failure Presentation AHA 2018 Atherosclerosis Up Next Presentation AHA 2018 Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial Presenter: Sotirios Tsimikas November 11, 2018 More slides + Presentation AHA 2018 High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT) Presenter: Gregory Piazza November 11, 2018 Presentation AHA 2018 PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure Presenter: Eric J Velazquez November 12, 2018 We Recommend
Presentation AHA 2018 Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial Presenter: Sotirios Tsimikas November 11, 2018
Presentation AHA 2018 High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT) Presenter: Gregory Piazza November 11, 2018
Presentation AHA 2018 PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure Presenter: Eric J Velazquez November 12, 2018